197 related articles for article (PubMed ID: 35467392)
61. Robbing Peter to Pay Paul: Chlorhexidine gluconate demonstrates short-term efficacy and long-term cytotoxicity.
Cheong JZA; Liu A; Rust CJ; Tran CL; Hassan SE; Kalan LR; Gibson ALF
Wound Repair Regen; 2022 Sep; 30(5):573-584. PubMed ID: 36638156
[TBL] [Abstract][Full Text] [Related]
62. 0.01% Hypochlorous Acid as an Alternative Skin Antiseptic: An In Vitro Comparison.
Anagnostopoulos AG; Rong A; Miller D; Tran AQ; Head T; Lee MC; Lee WW
Dermatol Surg; 2018 Dec; 44(12):1489-1493. PubMed ID: 29985866
[TBL] [Abstract][Full Text] [Related]
63. Hand hygiene for the prevention of infections in neonates.
Kuti BP; Ogunlesi TA; Oduwole O; Oringanje C; Udoh EE; Meremikwu MM
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013326. PubMed ID: 33471367
[TBL] [Abstract][Full Text] [Related]
64. Antimicrobial activity of a novel adhesive containing chlorhexidine gluconate (CHG) against the resident microflora in human volunteers.
Carty N; Wibaux A; Ward C; Paulson DS; Johnson P
J Antimicrob Chemother; 2014 Aug; 69(8):2224-9. PubMed ID: 24722839
[TBL] [Abstract][Full Text] [Related]
65. Efficacy of surgical skin preparation with chlorhexidine in alcohol according to the concentration required to prevent surgical site infection: meta-analysis.
Hasegawa T; Tashiro S; Mihara T; Kon J; Sakurai K; Tanaka Y; Morita T; Enoki Y; Taguchi K; Matsumoto K; Nakajima K; Takesue Y
BJS Open; 2022 Sep; 6(5):. PubMed ID: 36124902
[TBL] [Abstract][Full Text] [Related]
66. Impact of unit-wide chlorhexidine bathing in intensive care on bloodstream infection and drug-resistant organism acquisition.
Urbancic KF; Mårtensson J; Glassford N; Eyeington C; Robbins R; Ward PB; Williams D; Johnson PD; Bellomo R
Crit Care Resusc; 2018 Jun; 20(2):109-116. PubMed ID: 29852849
[TBL] [Abstract][Full Text] [Related]
67. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis.
O'Horo JC; Silva GL; Munoz-Price LS; Safdar N
Infect Control Hosp Epidemiol; 2012 Mar; 33(3):257-67. PubMed ID: 22314063
[TBL] [Abstract][Full Text] [Related]
68. Chlorhexidine (di)gluconate locking device for central line infection prevention in intensive care unit patients: a multi-unit, pilot randomized controlled trial.
Pook M; Zamir N; McDonald E; Fox-Robichaud A
Br J Nurs; 2022 Jul; 31(14):S36-S46. PubMed ID: 35856588
[TBL] [Abstract][Full Text] [Related]
69. Randomized controlled trial of chlorhexidine wash versus benzoyl peroxide soap for home surgical preparation: neither is effective in removing Cutibacterium from the skin of shoulder arthroplasty patients.
Hsu JE; Whitson AJ; Woodhead BM; Napierala MA; Gong D; Matsen FA
Int Orthop; 2020 Jul; 44(7):1325-1329. PubMed ID: 32385554
[TBL] [Abstract][Full Text] [Related]
70. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
[TBL] [Abstract][Full Text] [Related]
71. The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
Ames NJ; Barb JJ; Ranucci A; Kim H; Mudra SE; Cashion AK; Townsley DM; Childs R; Paster BJ; Faller LL; Wallen GR
Ann Hematol; 2019 Jun; 98(6):1351-1365. PubMed ID: 30919073
[TBL] [Abstract][Full Text] [Related]
72. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients.
Bleasdale SC; Trick WE; Gonzalez IM; Lyles RD; Hayden MK; Weinstein RA
Arch Intern Med; 2007 Oct; 167(19):2073-9. PubMed ID: 17954801
[TBL] [Abstract][Full Text] [Related]
73. Chlorhexidine Gluconate Baths: Supporting Daily Use to Reduce Central Line-Associated Bloodstream Infections Affecting Immunocompromised Patients.
Jusino-Leon GN; Matheson L; Forsythe L
Clin J Oncol Nurs; 2019 Apr; 23(2):E32-E38. PubMed ID: 30880801
[TBL] [Abstract][Full Text] [Related]
74. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections.
Suwantarat N; Carroll KC; Tekle T; Ross T; Maragakis LL; Cosgrove SE; Milstone AM
Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1183-6. PubMed ID: 25111928
[TBL] [Abstract][Full Text] [Related]
75. No infection reduction using chlorhexidine wipes in total joint arthroplasty.
Farber NJ; Chen AF; Bartsch SM; Feigel JL; Klatt BA
Clin Orthop Relat Res; 2013 Oct; 471(10):3120-5. PubMed ID: 23504539
[TBL] [Abstract][Full Text] [Related]
76. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections.
Quach C; Milstone AM; Perpête C; Bonenfant M; Moore DL; Perreault T
Infect Control Hosp Epidemiol; 2014 Feb; 35(2):158-63. PubMed ID: 24442078
[TBL] [Abstract][Full Text] [Related]
77. Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study.
Yasuda H; Sanui M; Abe T; Shime N; Komuro T; Hatakeyama J; Matsukubo S; Kawano S; Yamamoto H; Andoh K; Seo R; Inoue K; Noda E; Saito N; Nogami S; Okamoto K; Fuke R; Gushima Y; Kobayashi A; Takebayashi T; Lefor AK;
Crit Care; 2017 Dec; 21(1):320. PubMed ID: 29268759
[TBL] [Abstract][Full Text] [Related]
78. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant.
Adams D; Quayum M; Worthington T; Lambert P; Elliott T
J Hosp Infect; 2005 Dec; 61(4):287-90. PubMed ID: 16221509
[TBL] [Abstract][Full Text] [Related]
80. Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial.
Russell N; Clements MN; Azmery KS; Bekker A; Bielicki J; Dramowski A; Ellis S; Fataar A; Hoque M; LeBeau K; O'Brien S; Schiavone F; Skoutari P; Islam MS; Saha SK; Walker AS; Whitelaw A; Sharland M
EClinicalMedicine; 2024 Mar; 69():102463. PubMed ID: 38426071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
